First Citizens Bank & Trust’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-779
| Closed | -$10.9K | – | 456 |
|
|
2024
Q1 | $10.9K | Sell |
779
-1,084
| -58% | -$15.2K | ﹤0.01% | 429 |
|
|
2023
Q4 | $15.8K | Sell |
1,863
-1,558
| -46% | -$13.2K | ﹤0.01% | 357 |
|
|
2023
Q3 | $30.6K | Sell |
3,421
-3,121
| -48% | -$27.9K | ﹤0.01% | 346 |
|
|
2023
Q2 | $56.4K | Buy |
+6,542
| New | +$56.4K | ﹤0.01% | 347 |
|
|
2022
Q1 | – | Sell |
-994
| Closed | -$202K | – | 461 |
|
|
2021
Q4 | $202K | Buy |
994
+5
| +0.5% | +$1.02K | 0.01% | 418 |
|
|
2021
Q3 | $266K | Buy |
989
+68
| +7% | +$18.3K | 0.01% | 327 |
|
|
2021
Q2 | $237K | Sell |
921
-219
| -19% | -$56.4K | 0.01% | 356 |
|
|
2021
Q1 | $342K | Buy |
1,140
+333
| +41% | +$99.9K | 0.02% | 261 |
|
|
2020
Q4 | $206K | Buy |
+807
| New | +$206K | 0.01% | 354 |
|
|
2018
Q2 | – | Sell |
-137
| Closed | -$219K | – | 445 |
|
|
2018
Q1 | $219K | Buy |
+137
| New | +$219K | 0.03% | 383 |
|